Relmada Therapeutics (4E2.F) Q4 2024 Earnings

Nov 7Confirmed
Q2 2024
Q3 2024
Q4 2024
-0.79
-0.71
-0.62
-0.54

Details

Expected EPS
-0.62492175
Actual EPS
-0.6665832
Surprise EPS
-0.04
Surprise Percent
-6.67%

Description

⁨Relmada Therapeutics⁩ (⁦4E2.F⁩) has reported earnings of ⁦-0.6665832⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts